News | July 01, 2022
H Clinical adds commercial home health capabilities for pharma industry
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
The initiative pairs consumer engagement with a public health message about prevention and early detection
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Subscribe To Our Newsletter & Stay Updated
